These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35328849)

  • 41. Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.
    Johnstone G; Treharne GJ; Fletcher BD; Lamar RSM; White D; Harrison A; Stebbings S
    Rheumatol Int; 2021 Oct; 41(10):1763-1772. PubMed ID: 34297180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study.
    Pugliesi A; Sachetto Z; de Medeiros Pinheiro M; Salviato Pileggi G; Sarot Pereira da Cunha G; Hajar FN; Marques Negrisolli Cunha ML; Henrique da Mota LM; Lopes Marques CD; Kakehasi AM; Rodrigues Ferreira WH; Araújo NC; Monteiro Gomides Reis AP; Rodrigues de Abreu Vieira RM; Ferreira GA; Danowski A; de Souza VA; Soares Egypto de Brito DC; Dos Santos Paiva E; Provenza JR; Feijó Azevedo V
    J Clin Rheumatol; 2024 Jan; 30(1):e29-e33. PubMed ID: 35699528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses.
    Ahles TA; Khan SA; Yunus MB; Spiegel DA; Masi AT
    Am J Psychiatry; 1991 Dec; 148(12):1721-6. PubMed ID: 1957937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibromyalgia in human immunodeficiency virus infection.
    Buskila D; Gladman DD; Langevitz P; Urowitz S; Smythe HA
    J Rheumatol; 1990 Sep; 17(9):1202-6. PubMed ID: 2290162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subthreshold mood symptoms in patients with fibromyalgia and rheumatoid arthritis.
    Piccinni A; Bazzichi L; Marazziti D; Veltri A; Bombardieri S; Conversano C; Ciapparelli A; Dell'Osso L
    Clin Exp Rheumatol; 2011; 29(6 Suppl 69):S55-9. PubMed ID: 22132737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno
    Bozzalla Cassione E; Zanframundo G; Biglia A; Codullo V; Montecucco C; Cavagna L
    Ann Rheum Dis; 2021 May; 80(5):e66. PubMed ID: 32586917
    [No Abstract]   [Full Text] [Related]  

  • 47. The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey.
    Kahveci A; Gümüştepe A; Güven N; Ataman Ş
    Rheumatol Int; 2022 Apr; 42(4):601-608. PubMed ID: 35165770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapies for psoriatic enthesopathy. A systematic review.
    Ritchlin CT
    J Rheumatol; 2006 Jul; 33(7):1435-8. PubMed ID: 16724370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic.
    Favalli EG; Maioli G; Biggioggero M; Caporali R
    Expert Rev Clin Immunol; 2021 Jun; 17(6):561-571. PubMed ID: 33787418
    [No Abstract]   [Full Text] [Related]  

  • 50. Weight loss affects disease activity and treatment response in inflammatory rheumatic diseases.
    Tournadre A; Beauger M
    Joint Bone Spine; 2024 May; 91(3):105647. PubMed ID: 37783311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
    Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J
    RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seasonal symptom severity in patients with rheumatic diseases: a study of 1,424 patients.
    Hawley DJ; Wolfe F; Lue FA; Moldofsky H
    J Rheumatol; 2001 Aug; 28(8):1900-9. PubMed ID: 11508598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Online management of rheumatoid arthritis during COVID-19 pandemic.
    Zhang Y; Wang J; Zhao L; Xiao J; Shi Z
    Ann Rheum Dis; 2021 Jan; 80(1):e4. PubMed ID: 32340979
    [No Abstract]   [Full Text] [Related]  

  • 54. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort.
    Lee YC; Lu B; Boire G; Haraoui BP; Hitchon CA; Pope JE; Thorne JC; Keystone EC; Solomon DH; Bykerk VP
    Ann Rheum Dis; 2013 Jun; 72(6):949-54. PubMed ID: 22791744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoimmune rheumatic disease associated symptoms in fibromyalgia patients and their influence on anxiety, depression and somatisation: a comparative study.
    Dönmez S; Pamuk ÖN; Ümit EG; Top MŞ
    Clin Exp Rheumatol; 2012; 30(6 Suppl 74):65-9. PubMed ID: 23137613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina
    Bozzalla Cassione E; Zanframundo G; Biglia A; Codullo V; Montecucco C; Cavagna L
    Ann Rheum Dis; 2021 Apr; 80(4):e51. PubMed ID: 32503850
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of COVID-19 Pandemic Lockdown on Fibromyalgia Symptoms.
    Batres-Marroquín AB; Medina-García AC; Vargas Guerrero A; Barrera-Villalpando MI; Martínez-Lavín M; Martínez-Martínez LA
    J Clin Rheumatol; 2022 Jan; 28(1):e289-e291. PubMed ID: 33264250
    [No Abstract]   [Full Text] [Related]  

  • 58. Response to 'Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort' by Ruyssen-Witrand
    Ciurea A; Finckh A
    Ann Rheum Dis; 2023 Feb; 82(2):e33. PubMed ID: 33177100
    [No Abstract]   [Full Text] [Related]  

  • 59. COVID-19 related poor mental health and sleep disorders in rheumatic patients: a citizen science project.
    Ingegnoli F; Buoli M; Posio C; Di Taranto R; Lo Muscio A; Cumbo E; Ostuzzi S; Caporali R
    BMC Psychiatry; 2021 Aug; 21(1):385. PubMed ID: 34344329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Responding to and Driving Change in Rheumatology: Report from the 12th International Immunology Summit 2021.
    Felten R; Rosine N
    Rheumatol Ther; 2022 Apr; 9(2):705-719. PubMed ID: 35279812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.